Home - ICHP KeePosted

Official Newsjournal of the Illinois Council of Health-System Pharmacists

Professional Affairs
Position Statement Updates

The Division of Professional Affairs has been busy reviewing and updating the subgroup of position statements that were last reviewed in 2018. These are the highlights of the position statements presented and accepted at the May 2021 Board meeting.

Chemical Dependency

Wordsmithing completed and addition of a clause for workplaces to include surveillance and treatment programs for impaired employees.

Differentiating Nomenclatures for Biosimilars

Removed redundant FDA recommendations.

Drug Testing in the Workplace

Addition of a statement that employers should have a policy and procedure which offers an employer-sponsored addiction recovery program that supports impaired individuals

Manufacturer Drug Shortages

Addition of a statement that ICHP does not support the use of the gray market as a source for products in short supply (refer to Pharmaceutical Gray Market Position Statement.)

Medical Marijuana

Addition of a statement that ICHP advocates for the education of purchasers on known health risks associated with the use of cannabis at the time of purchase. Also, the word ‘marijuana’ was replaced with ‘cannabis’ in order to use a more global term.

Pharmaceutical Gray Market

Identified key principles that affect how drug suppliers/vendors should be selected.

Prescriber Dispensing

Wordsmithing completed.

Prescription Drug Reclassification

No changes made.

View a full list of ICHP's position statements on our website: www.ichpnet.org/pharmacy_practice/professional_practice/ichp_position_statements/